跳至主要内容
临床试验/DRKS00026758
DRKS00026758招募中2 期

Randomized controlled trial to investigate the efficacy of the Draeger Companion med treatment unit for alcohol dependence. - Dräger Companion med

Dräger Safety AG & Co. KGaA0 个研究点目标入组 56 人开始时间: 2022年1月27日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Diagnosed alcohol dependence according to ICD-10-GM F10.2
  • - Intention to stop alcohol consumption
  • - Age = 18 years
  • - Resident (registered primary residence) in the Federal Republic of Germany.
  • - Willingness to participate in the study
  • - Completed physical detoxification
  • - Legal capacity

排除标准

  • - Dependence on other psychotropic substances (except tobacco and caffeine)
  • - Acute psychiatric illness requiring treatment or suicidality
  • - Severe cognitive impairment
  • - Abstinence has existed for longer than 6 weeks prior to baseline interview
  • - Lack of German language skills
  • - Acute concomitant illness at the time of individual study entry that requires short-term inpatient admission is required
  • - Impairment of vision that prevents the intended use of the product prevented
  • - Use of another app or web application for alcohol cessation or consumption control
  • - Participation in another (non-digital) program for alcohol cessation or consumption control (current or in the past 3 months)
  • - Existing dependent relationship with a person involved in the study
  • - Members of vulnerable populations (e.g., incarcerated, pregnant, breastfeeding)

研究者

发起方
Dräger Safety AG & Co. KGaA

相似试验